-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
HBV-IN-17
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/2270943-13-8.gif)
| Category | Hepatitis B Virus (HBV) |
| CAS | 2270943-13-8 |
| Description | HBV-IN-17 (compound 8) is a potent HBV capsid assembly modulator with an EC50 of 511 nM. |
Product Information
| Synonyms | HBV-IN-17|SCHEMBL20691647|HY-144320|CS-0379485|7-N-(3,4,5-trifluorophenyl)-1-N-[(2R)-1,1,1-trifluoropropan-2-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-1,7-dicarboxamide |
| Molecular Weight | 435.32 |
| Molecular Formula | C17H15F6N5O2 |
| Canonical SMILES | CC(C(F)(F)F)NC(=O)C1=C2CN(CCN2C=N1)C(=O)NC3=CC(=C(C(=C3)F)F)F |
| Purity | ≥98% (HPLC) |
| Solubility | 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 641 |
| Exact Mass | 435.11299371 |
| Target | HBV |
| XLogP3-AA | 1.9 |
